Product References
Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13).
Autoimmunity reviews
Bossuyt X,Vulsteke JB,Van Elslande J,Boon L,Wuyts G,Willebrords S,Frans G,Geukens N,Carpentier S,Tejpar S,Wildiers H,Blockmans D,De Langhe E,Vermeersch P,Derua R
Sat Apr 01 00:00:00 EDT 2023
KIFC3 regulates progression of hepatocellular carcinoma via EMT and the AKT/mTOR pathway.
Experimental cell research
Lu S,Liu Y,Tian S,He Y,Dong W
Mon May 01 00:00:00 EDT 2023
TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway.
Oncology reports
Xiao Z,Li M,Zhang X,Rong X,Xu H
Mon May 01 00:00:00 EDT 2023
TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway.
Oncology reports
Xiao Z,Li M,Zhang X,Rong X,Xu H
Mon May 01 00:00:00 EDT 2023
TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway.
Oncology reports
Xiao Z,Li M,Zhang X,Rong X,Xu H
Mon May 01 00:00:00 EDT 2023
Trip13 Depletion in Liver Cancer Induces a Lipogenic Response Contributing to Plin2-Dependent Mitotic Cell Death.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Rios Garcia M,Meissburger B,Chan J,de Guia RM,Mattijssen F,Roessler S,Birkenfeld AL,Raschzok N,Riols F,Tokarz J,Giroud M,Gil Lozano M,Hartleben G,Nawroth P,Haid M,López M,Herzig S,Berriel Diaz M
Sat Oct 01 00:00:00 EDT 2022
Trip13 Depletion in Liver Cancer Induces a Lipogenic Response Contributing to Plin2-Dependent Mitotic Cell Death.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Rios Garcia M,Meissburger B,Chan J,de Guia RM,Mattijssen F,Roessler S,Birkenfeld AL,Raschzok N,Riols F,Tokarz J,Giroud M,Gil Lozano M,Hartleben G,Nawroth P,Haid M,López M,Herzig S,Berriel Diaz M
Sat Oct 01 00:00:00 EDT 2022
Trip13 Depletion in Liver Cancer Induces a Lipogenic Response Contributing to Plin2-Dependent Mitotic Cell Death.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Rios Garcia M,Meissburger B,Chan J,de Guia RM,Mattijssen F,Roessler S,Birkenfeld AL,Raschzok N,Riols F,Tokarz J,Giroud M,Gil Lozano M,Hartleben G,Nawroth P,Haid M,López M,Herzig S,Berriel Diaz M
Sat Oct 01 00:00:00 EDT 2022
Trip13 Depletion in Liver Cancer Induces a Lipogenic Response Contributing to Plin2-Dependent Mitotic Cell Death.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Rios Garcia M,Meissburger B,Chan J,de Guia RM,Mattijssen F,Roessler S,Birkenfeld AL,Raschzok N,Riols F,Tokarz J,Giroud M,Gil Lozano M,Hartleben G,Nawroth P,Haid M,López M,Herzig S,Berriel Diaz M
Sat Oct 01 00:00:00 EDT 2022
Inducing Synergistic DNA Damage by TRIP13 and PARP1 Inhibitors Provides a Potential Treatment for Hepatocellular Carcinoma.
Journal of Cancer
Xu H,Ma Z,Mo X,Chen X,Xu F,Wu F,Chen H,Zhou G,Xia H,Zhang C
Sat Jul 16 00:00:00 EDT 2022
Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways.
Journal of cellular and molecular medicine
Lan J,Huang J,Tao X,Gao Y,Zhang L,Huang W,Luo J,Liu C,Deng Y,Liu L,Liu X
Sun May 01 00:00:00 EDT 2022
Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways.
Journal of cellular and molecular medicine
Lan J,Huang J,Tao X,Gao Y,Zhang L,Huang W,Luo J,Liu C,Deng Y,Liu L,Liu X
Sun May 01 00:00:00 EDT 2022
Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways.
Journal of cellular and molecular medicine
Lan J,Huang J,Tao X,Gao Y,Zhang L,Huang W,Luo J,Liu C,Deng Y,Liu L,Liu X
Sun May 01 00:00:00 EDT 2022
Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways.
Journal of cellular and molecular medicine
Lan J,Huang J,Tao X,Gao Y,Zhang L,Huang W,Luo J,Liu C,Deng Y,Liu L,Liu X
Sun May 01 00:00:00 EDT 2022
TRIP13 promotes the proliferation and invasion of lung cancer cells via the Wnt signaling pathway and epithelial-mesenchymal transition.
Journal of molecular histology
Li ZH,Lei L,Fei LR,Huang WJ,Zheng YW,Yang MQ,Wang Z,Liu CC,Xu HT
Mon Feb 01 00:00:00 EST 2021
SKP1 drives the prophase I to metaphase I transition during male meiosis.
Science advances
Guan Y,Leu NA,Ma J,Chmátal L,Ruthel G,Bloom JC,Lampson MA,Schimenti JC,Luo M,Wang PJ
Sun Mar 01 00:00:00 EST 2020
TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status.
Molecular oncology
Agarwal S,Behring M,Kim HG,Chandrashekar DS,Chakravarthi BVSK,Gupta N,Bajpai P,Elkholy A,Al Diffalha S,Datta PK,Heslin MJ,Varambally S,Manne U
Tue Dec 01 00:00:00 EST 2020
TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis.
British journal of cancer
Zhang G,Zhu Q,Fu G,Hou J,Hu X,Cao J,Peng W,Wang X,Chen F,Cui H
Sun Dec 01 00:00:00 EST 2019
TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis.
British journal of cancer
Zhang G,Zhu Q,Fu G,Hou J,Hu X,Cao J,Peng W,Wang X,Chen F,Cui H
Sun Dec 01 00:00:00 EST 2019
TRIP13 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Pathology, research and practice
Di S,Li M,Ma Z,Guo K,Li X,Yan X
Sat Jun 01 00:00:00 EDT 2019
The PSMA8 subunit of the spermatoproteasome is essential for proper meiotic exit and mouse fertility.
PLoS genetics
Gómez-H L,Felipe-Medina N,Condezo YB,Garcia-Valiente R,Ramos I,Suja JA,Barbero JL,Roig I,Sánchez-Martín M,de Rooij DG,Llano E,Pendas AM
Thu Aug 01 00:00:00 EDT 2019
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.
Cell death & disease
Sheng N,Yan L,Wu K,You W,Gong J,Hu L,Tan G,Chen H,Wang Z
Wed Mar 14 00:00:00 EDT 2018
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.
Cell death & disease
Sheng N,Yan L,Wu K,You W,Gong J,Hu L,Tan G,Chen H,Wang Z
Wed Mar 14 00:00:00 EDT 2018
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.
Cell death & disease
Sheng N,Yan L,Wu K,You W,Gong J,Hu L,Tan G,Chen H,Wang Z
Wed Mar 14 00:00:00 EDT 2018
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.
Cell death & disease
Sheng N,Yan L,Wu K,You W,Gong J,Hu L,Tan G,Chen H,Wang Z
Wed Mar 14 00:00:00 EDT 2018
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.
Cell death & disease
Sheng N,Yan L,Wu K,You W,Gong J,Hu L,Tan G,Chen H,Wang Z
Wed Mar 14 00:00:00 EDT 2018
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.
Cell death & disease
Sheng N,Yan L,Wu K,You W,Gong J,Hu L,Tan G,Chen H,Wang Z
Wed Mar 14 00:00:00 EDT 2018
TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.
Nature communications
Banerjee R,Russo N,Liu M,Basrur V,Bellile E,Palanisamy N,Scanlon CS,van Tubergen E,Inglehart RC,Metwally T,Mani RS,Yocum A,Nyati MK,Castilho RM,Varambally S,Chinnaiyan AM,D'Silva NJ
Thu Jul 31 00:00:00 EDT 2014
TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.
Nature communications
Banerjee R,Russo N,Liu M,Basrur V,Bellile E,Palanisamy N,Scanlon CS,van Tubergen E,Inglehart RC,Metwally T,Mani RS,Yocum A,Nyati MK,Castilho RM,Varambally S,Chinnaiyan AM,D'Silva NJ
Thu Jul 31 00:00:00 EDT 2014